Progressive Age-Related Cognitive Decline in Tau Mice

被引：36

作者：

Van der Jeugd, Ann ^{[1
]}

Vermaercke, Ben ^{[1
]}

Derisbourg, Maxime ^{[2
,3
]}

Lo, Adrian C. ^{[1
]}

Hamdane, Malika ^{[2
,3
]}

Blum, David ^{[2
,3
,4
]}

Buee, Luc ^{[2
,3
,4
]}

D'Hooge, Rudi ^{[1
]}

机构：

[1] Univ Leuven, Fac Psychol & Educ Sci, Lab Biol Psychol, Louvain, Belgium

[2] Univ Lille Nord France, UDSL, Lille, France

[3] INSERM, Jean Pierre Aubert Res Ctr, IMPRT, U837, F-59045 Lille, France

[4] CHRU Lille, CMRR, F-59037 Lille, France

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2013年 / 37卷 / 04期

关键词：

aging; learning; memory; tauopathy; transgenic model; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; LONG-TERM POTENTIATION; MORRIS WATER MAZE; ALZHEIMERS-DISEASE; SYNAPTIC-TRANSMISSION; MEMORY DEFICITS; DEPENDENT IMPAIRMENT; ODOR DISCRIMINATION; HIPPOCAMPAL-NEURONS;

D O I：

10.3233/JAD-130110

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Age-related cognitive decline and neurodegenerative diseases are a growing challenge for society. Accumulation of tau pathology has been proposed to partially contribute to these impairments. This study provides a behavioral characterization during aging of transgenic mice bearing tau mutations. THY-Tau22 mice were evaluated at ages wherein tau neuropathology in this transgenic mouse model is low (3-4 months), moderate (6-7 months), or extensive (>9 months). Spatial memory was found to be impaired only after 9 months of age in THY-Tau22 mice, whereas non-spatial memory was affected as early as 6 months, appearing to offer an opportunity for assessing potential therapeutic agents in attenuating or preventing tauopathies through modulation of tau kinetics.

引用

页码：777 / 788

页数：12

共 50 条

[1] A novel approach to rapidly prevent age-related cognitive decline
Adlard, Paul A.
Sedjahtera, Amelia
Gunawan, Lydia
Bray, Lisa
Hare, Dominic
Lear, Jessica
Doble, Philip
Bush, Ashley I.
Finkelstein, David I.
Cherny, Robert A.
AGING CELL, 2014, 13 (02) : 351 - 359
[2] Hippocampal gene expression changes during age-related cognitive decline
Pawlowski, Traci L.
Bellush, Linda L.
Wright, Amy W.
Walker, Jon P.
Colvin, Robert A.
Huentelman, Matthew J.
BRAIN RESEARCH, 2009, 1256 : 101 - 110
[3] Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline
Yurko-Mauro, Karin
McCarthy, Deanna
Rom, Dror
Nelson, Edward B.
Ryan, Alan S.
Blackwell, Andrew
Salem, Norman, Jr.
Stedman, Mary
ALZHEIMERS & DEMENTIA, 2010, 6 (06) : 456 - 464
[4] The Role of Neurotrophin Signaling in Age-Related Cognitive Decline and Cognitive Diseases
Numakawa, Tadahiro
Odaka, Haruki
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
[5] A dietary supplement abolishes age-related cognitive decline on transgenic mice expressing elevated free radical processes
Lemon, JA
Boreham, DR
Rollo, CD
EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (07) : 800 - 810
[6] Epigenetic alterations in the suprachiasmatic nucleus and hippocampus contribute to age-related cognitive decline
Deibel, Scott H.
Zelinski, Erin L.
Keeley, Robin J.
Kovalchuk, Olga
McDonald, Robert J.
ONCOTARGET, 2015, 6 (27) : 23181 - 23203
[7] Interleukin 6 reduces allopregnanolone synthesis in the brain and contributes to age-related cognitive decline in mice
Parks, Eileen E.
Logan, Sreemathi
Yeganeh, Alexander
Farley, Julie A.
Owen, Daniel B.
Sonntag, William E.
JOURNAL OF LIPID RESEARCH, 2020, 61 (10) : 1308 - 1319
[8] Age-related cognitive decline is associated with microbiota-gut-brain axis disorders and neuroinflammation in mice
Wu, Mei-Ling
Yang, Xue-Qin
Xue, Li
Duan, Wei
Du, Jun-Rong
BEHAVIOURAL BRAIN RESEARCH, 2021, 402
[9] Pathways to age-related cognitive decline
Kramer, Joel
ANNALS OF NEUROLOGY, 2013, 73 (05) : 563 - 564
[10] Dehydroepiandrosterone and age-related cognitive decline
Sorwell, Krystina G.
Urbanski, Henryk F.
AGE, 2010, 32 (01) : 61 - 67

← 1 2 3 4 5 →